Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100,000
Closed -$603K 43
2023
Q2
$603K Sell
100,000
-222,300
-69% -$1.39M 0.03% 43
2023
Q1
$2.33M Sell
322,300
-57,500
-15% -$469K 1.04% 35
2022
Q4
$3.44M Sell
379,800
-105,900
-22% -$942K 1.67% 29
2022
Q3
$3.64M Sell
485,700
-164,350
-25% -$1.24M 1.82% 26
2022
Q2
$4M Sell
650,050
-253,950
-28% -$1.77M 1.77% 27
2022
Q1
$6.86M Sell
904,000
-70,800
-7% -$539K 2.32% 18
2021
Q4
$8.2M Buy
+974,800
New +$8.31M 2.36% 15

Other funds holding ADT

Patient Capital Management's ADT Position: Q3 2023 in Review

Patient Capital Management sold out of ADT (ADT) in Q3 2023, closing a stake of 100,000 shares — an estimated $603K sold.

Patient Capital Management first reported a position in ADT in Q4 2021 and held it in 7 quarters. The position peaked at $8.2M in Q4 2021. 206 funds tracked by Wall St. Rank hold ADT as of Q3 2023.

  • Patient Capital Management reported no remaining ADT position as of Q3 2023 after selling out during the quarter.
  • Patient Capital Management sold 100,000 ADT shares in Q3 2023, an estimated $603K.
  • Patient Capital Management first reported a position in ADT in Q4 2021 and held it in 7 quarters.
  • Patient Capital Management's ADT position peaked at $8.2M in Q4 2021.
  • 206 funds tracked by Wall St. Rank held ADT as of Q3 2023.

Based on Patient Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.